Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Completed 3 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 13 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 5 Prostatic Neoplasms 4 Neoplasm Metastasis 3 Melanoma 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Multiple Myeloma 2 Lung Neoplasms 2 Liver Neoplasms 2 Glioblastoma 2 Fibrosis 2 Colorectal Neoplasms 2 Cachexia 2 Vascular Malformations 1 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Renal Insufficiency, Chronic 1 Recurrence 1 Pneumonia 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Osteosarcoma 1 Obesity 1

Interventions

Cyclophosphamide 24 Mycophenolic Acid 15 fludarabine phosphate 14 fludarabine 13 Whole-Body Irradiation 13 Tacrolimus 12 Rituximab 12 Melphalan 12 Filgrastim 11 Cyclosporine 11 Busulfan 11 Radiotherapy 10 Peripheral Blood Stem Cell Transplantation 10 Antilymphocyte Serum 10 Methotrexate 9 Doxorubicin 9 Gemcitabine 8 Etoposide 8 Brentuximab Vedotin 8 Sirolimus 7 pembrolizumab 6 Vinblastine 6 Nivolumab 6 Methylprednisolone 6 Granulocyte Colony-Stimulating Factor 6 Alemtuzumab 6 Dacarbazine 5 Cytarabine 5 Cord Blood Stem Cell Transplantation 5 Carmustine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hodgkin Disease × Blood Specimen Collection × Clear all

NCT04621604 2023-10-31

REVOLUMHOD

Rennes University Hospital

Phase NA Terminated

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡